Clinical Trial Update: Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1 [Phase 2]

View source ↗

Summary

An open-label Phase 2 safety study evaluating the combination of telaprevir and sofosbuvir in adults with chronic hepatitis C genotype 1; results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sofosbuvir (Sovaldi) (sofosbuvir)
• Telaprevir (Incivek) (telaprevir)

Snippet

Sponsor: University of Florida | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2015-03-06